SCHEMBL4693070

SCHEMBL4693070

COC(=O)N(CC(=O)OC(C)(C)C)C(C(=O)O)c1cccs1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSTO1 P78417 1/20 0.36
LMNA P02545 4/20 0.35
NPSR1 Q6W5P4 3/20 0.35
POLB P06746 2/20 0.35
TP53 P04637 1/20 0.35
THRB P10828 1/20 0.35
CTSS P25774 1/20 0.35
CTSK P43235 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
KDM4E B2RXH2 2/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4138910 0.91 GSTO1 (0.36) GSTO1LMNANPSR1POLBTP53
SCHEMBL4693729 0.85 LMNA (0.39) LMNANPSR1POLBTP53THRB
SCHEMBL5255513 0.83 CASR (0.43) GSTO1CTSSCTSKL3MBTL1ALDH1A1
SCHEMBL5185241 0.77 NPSR1 (0.39) LMNANPSR1POLBTP53THRB
SCHEMBL5185704 0.77 KMT2A (0.43) CTSSCTSKL3MBTL1MEN1KMT2A
SCHEMBL7410328 0.72 POLB (0.40) GSTO1LMNANPSR1POLBTP53
SCHEMBL7407275 0.72 POLB (0.40) GSTO1LMNANPSR1POLBTP53
SCHEMBL4838520 0.72 KMT2A (0.49) LMNAPOLBTHRBL3MBTL1KDM4E
SCHEMBL4693687 0.72 CTSK (0.38) GSTO1LMNANPSR1POLBTP53
SCHEMBL5185377 0.71 SMN1; SMN2 (0.38) CTSSCTSKKDM4ENPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1569935-B1 HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREOF AND USE OF SAME AS MEDICAMENTS, SUCH AS ANTI-BACTERIAL MEDICAMENTS AND BETA-LACTAMASE INHIBITORS NOVEXEL (FR) 2008-08-20 EP disclosed
EP-1798231-A2 Intermediate products for the preparation of antibacterial compounds NOVEXEL (FR) 2007-06-20 EP disclosed
EP-1399444-B1 NOVEL HETEROCYCLIC COMPOUNDS, METHOD FOR PREPARING SAME AND USE THEREOF AS MEDICINES, IN PARTICULAR AS ANTI-BACTERIAL AGENTS NOVEXEL (FR) 2007-04-11 EP disclosed